← Back to guidelines
Otolaryngology (ENT)131 papers

Anaerobic cellulitis

Last edited: 4/15/2026

Overview

Anaerobic cellulitis refers to infections caused by anaerobic bacteria, often involving deep soft tissues and characterized by severe inflammation and suppuration. These infections can arise from various sources, including trauma, surgical sites, and underlying infections like abscesses 2.

Diagnosis

  • Clinical presentation includes localized pain, swelling, erythema, and warmth 2.
  • Cultures of infected tissue or aspirated fluid are crucial for identifying the causative anaerobic bacteria 2.
  • Imaging (e.g., ultrasound, MRI) may help assess extent and guide drainage procedures 2.
  • Management

  • First-line treatment: Metronidazole or clindamycin are commonly used 2.
  • Adjunctive therapy: Surgical drainage of abscesses is often necessary 2.
  • Duration: Treatment typically lasts 7-14 days, adjusted based on clinical response and culture results 2.
  • Special Populations

  • Pregnancy: Metronidazole use requires caution due to potential risks; alternatives like clindamycin may be preferred 1.
  • Elderly: Increased vigilance for complications and adherence to thorough surgical and antibiotic management is advised 2.
  • Key Recommendations

  • Initiate empirical antibiotic therapy targeting anaerobes early in suspected cases (Evidence: Moderate 2).
  • Ensure prompt surgical intervention for abscess drainage (Evidence: Moderate 2).
  • Monitor for adverse events, particularly gastrointestinal issues, with nitroimidazole use (Evidence: Weak 1).
  • References

    1 Wu Q, Wu F, Jiang H, Jiang L, Zhang X, Guo C et al.. Safety Evaluation of Nitroimidazole Antibiotics Based on the FAERS Database. Clinical and experimental pharmacology & physiology 2025. link 2 Willis AT. Anaerobic bacterial diseases now and then: where do we go from here?. Reviews of infectious diseases 1984. link

    Original source

    1. [1]
      Safety Evaluation of Nitroimidazole Antibiotics Based on the FAERS Database.Wu Q, Wu F, Jiang H, Jiang L, Zhang X, Guo C et al. Clinical and experimental pharmacology & physiology (2025)
    2. [2]
      Anaerobic bacterial diseases now and then: where do we go from here?Willis AT Reviews of infectious diseases (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG